GLP-1 and Smoking Cessation Research
Emerging research suggests semaglutide may reduce tobacco use, an unexpected finding still being actively studied. Here...
How GLP-1 works in the body β the hormone science behind appetite, blood sugar and modern weight-loss medicine.
Emerging research suggests semaglutide may reduce tobacco use, an unexpected finding still being actively studied. Here...
A small pilot study found a GLP-1 medication roughly halved monthly migraine days in people with obesity, independent of...
Every GLP-1 medication available and in development, what each is approved for, how much weight each produces, and which...
These drugs reduce cardiovascular events, protect kidneys and improve several conditions independently of the scale. Her...
Retatrutide targets three hormone receptors and produced 24.2 percent weight loss in phase 2 trials. Learn how it works,...
Orforglipron was approved in April 2026 as a daily GLP-1 tablet with no food or water restrictions. Learn how it works,...
CagriSema combines semaglutide with cagrilintide, an amylin analogue targeting a separate fullness pathway. Learn how it...
Survodutide is a GLP-1 and glucagon dual agonist from Boehringer Ingelheim. Learn its phase 3 SYNCHRONIZE results, how i...
Mazdutide was approved in China in June 2025 for weight management. Learn how this GLP-1 and glucagon dual agonist works...